Soy and pea peptides

Soy peptides, soybean protein hydrolysate, pea protein hydrolysate, pea peptides, plant-derived ACE-inhibitory peptides, soymorphins

Food-derived & nutrition

Awaiting medical reviewEN ES DE FR PT ZH+ Follow for updates

Summary

Class: Food-derived peptide mixtures from enzymatic hydrolysis of soybean (glycinin, β-conglycinin) or pea (legumin, vicilin) storage proteins; hundreds of short peptides per product
Mechanism: Fractions inhibit ACE and DPP-4 in vitro, modulate lipid metabolism (β-conglycinin-derived peptides lower hepatic fat in rodents), and act as fast-absorbed amino-acid sources for muscle
Routes studied: Oral (powders, drinks, fortified foods)
Dose range reported: Human trials: soy protein 25 g/day (the FDA claim level, whole protein); soy peptide hydrolysates 3–8 g/day; pea protein hydrolysate 20–50 g/day in muscle trials; pea ACE-inhibitory hydrolysate ~3 g/day in a BP study. Typical product servings 20–30 g protein
Half-life: Minutes to a few hours; di/tripeptides appear in plasma 30–120 min post-ingestion
Storage: Dry powder: room temperature, sealed, dry
Regulatory status: Food ingredients; no medicinal approval; soy protein carries a qualified heart-health claim in the US (under review)

Doses are as reported in studies or by the community — never recommendations.

1What it is

Soy and pea proteins are the two main plant proteins used in supplements and meat alternatives. When they are partly digested by enzymes, the resulting hydrolysates contain short peptides, some of which show biological activity in the laboratory. This profile is about those peptide fractions. Whole soy protein's cholesterol-lowering effect is the best-established finding in the field and is largely a protein and isoflavone effect, not a specific peptide one; it is included because the two are constantly conflated in marketing.

Soy peptides have been a functional-food category in Japan since the 1990s. Pea protein hydrolysate has grown recently as a non-soy, non-dairy alternative. Both are ordinary food constituents.

2How it's thought to work

ACE inhibition. short peptides from both soy and pea inhibit ACE ; pea-derived fractions also inhibit renin (Li & Aluko 2010).

DPP-4 inhibition. some soy and pea dipeptides weakly inhibit DPP-4, the enzyme that degrades GLP-1, in vitro.

Lipid metabolism. β-conglycinin and its peptides increase LDL-receptor expression and faecal bile-acid excretion in animals; soy protein's LDL effect may partly reflect displacing animal protein.

Muscle. pea protein is relatively high in leucine (~8%) and in hydrolysed form is absorbed quickly; muscle effects are amino-acid driven.

Soymorphins. short opioid-like peptides from β-conglycinin reduce food intake in mice (Kaneko 2010); no human data.

Plant protein hydrolysates. Absorbed as small fragments and amino acids; the blood-pressure and antioxidant claims rest mainly on cell and animal work.Schematic — not to scale

3What the research shows

LDL cholesterol (whole soy protein)

Meta-analyses of ~40–50 show that ~25 g/day soy protein lowers LDL by roughly 3–5% (Jenkins 2019, J Nutr; Blanco Mejia 2019). This underpins the US FDA health claim (1999); in 2017 FDA proposed revoking it because later trials were inconsistent, and the proposal remains unresolved †. The effect is attributed to protein plus isoflavones rather than defined peptides. [1][2]

Blood pressure (soy and pea hydrolysates)

Small trials: a soy peptide drink reduced BP modestly in Japanese adults with mild hypertension (several small manufacturer studies 2000s); a pea protein hydrolysate (3 g/day for 3 weeks) reduced systolic BP by ~5–6 mmHg in a small Canadian pilot (Li 2011, J Agric Food Chem). Not replicated at scale; EFSA has no authorised claim. [6]

Graded A (non-inferiority to whey)

Muscle mass and strength (pea protein)

In 161 men doing 12 weeks of resistance training, 25 g pea protein twice daily increased biceps thickness more than placebo and comparably to whey (Babault 2015, J Int Soc Sports Nutr). Later trials confirm pea is roughly equivalent to whey for muscle gains when total protein and leucine are matched (Banaszek 2019, Sports). This is a protein effect, not a peptide-specific one. [3][4]

Glucose and satiety

Pea and soy hydrolysates acutely raise insulin and GLP-1 and reduce post-meal glucose in small studies (Smith 2012 — pea; several soy studies). Effects similar in direction to whey (profile 172) but generally smaller.

Graded B/—

Fatigue, cognition, "soy peptide" functional claims

Small Japanese trials report reduced fatigue scores and improved mood after soy peptide intake; low quality, industry-linked.

Graded C/B

Liver fat and body weight

Rodent studies show β-conglycinin peptides reduce hepatic triglycerides; small human trials of β-conglycinin (5 g/day) reported reduced visceral fat and triglycerides (Kohno 2006, J Atheroscler Thromb). Single-group studies. [7]

4Reported side effects and interactions

Literature-reported

well tolerated; bloating, flatulence (oligosaccharides in less-purified pea products), bitter taste of hydrolysates. Soy and pea (legume) allergy are contraindications; pea allergy is rising and cross-reacts with peanut in some people.

Community-reported

gas and bloating with pea protein; "soy and hormones" worries relate to isoflavones, which are mostly removed from isolates and hydrolysates.

Theoretical. high soy intake can reduce absorption of levothyroxine and may slightly affect thyroid function in iodine-deficient people; pea protein is low in methionine, soy in methionine/cysteine — both are complete but lower-quality than whey on digestibility scores.

Interactions. levothyroxine (separate dosing by 4 h); soy protein may reduce warfarin effect in case reports; any ACE-inhibitory peptide theoretically adds to antihypertensives.

Markers researchers commonly monitor

Marker	Why it's watched
Lipid panel	the only robust human outcome, and only for whole soy protein at ~25 g/day.
Home blood pressure	if used for the ACE-inhibitory hypothesis; expect small effects at most.
Body composition and strength	for pea protein as a muscle-building protein.
TSH / free T4	people on levothyroxine or with marginal iodine intake using large soy amounts.
No compound-specific blood markers are established

Free for everyone. Safety information is never behind a paywall.

5Formulation and handling

Supplied as powders (isolate vs hydrolysate — labels do not always distinguish), ready-to-drink products and bars. Degree of hydrolysis determines bitterness and the peptide profile; most sports products are isolates, not true hydrolysates. Store dry. No calculator applies.

6Commonly studied alongside

Whey-derived peptides (profile 172) as the comparator; lunasin (profile 174), which is a specific soy peptide; collagen peptides (profile 171) in blended products; creatine and leucine in sports contexts.

Informational cross-links. Not stack recommendations.

7Regulatory status by region

Region	Status (checked —)
United States	Food / dietary supplement; soy protein heart-health claim authorised 1999, revocation proposed 2017 and still pending †
European Union	Food / food supplement; EFSA rejected soy-protein LDL claims (2010, 2012); no authorised peptide claims
United Kingdom	Food supplement; as EU
Australia	Food; FSANZ permits a general soy protein and cholesterol claim under certain conditions †
South Africa	Food
Sport	Not prohibited by WADA

8Open questions

Whether any defined soy or pea peptide, rather than the whole protein, has a clinical effect in humans at food doses.
Bioavailability of ACE-inhibitory peptides after digestion.
Independent replication of the small Japanese soy-peptide functional trials.

9References

1Jenkins DJA et al. (2019). Cumulative meta-analysis of the soy effect over time. J Am Heart Assoc [verify journal]. PubMed · DOI
2Blanco Mejia S et al. (2019). A meta-analysis of 46 studies identified by the FDA demonstrates that soy protein decreases circulating LDL and total cholesterol concentrations in adults. J Nutr. DOI
3Babault N et al. (2015). Pea proteins oral supplementation promotes muscle thickness gains during resistance training: a double-blind, randomized, placebo-controlled clinical trial vs. whey protein. J Int Soc Sports Nutr. PubMed · DOI
4Banaszek A et al. (2019). The effects of whey vs. pea protein on physical adaptations following 8 weeks of high-intensity functional training. Sports. PubMed · DOI
5Li H, Aluko RE (2010). Identification and inhibitory properties of multifunctional peptides from pea protein hydrolysate. J Agric Food Chem. PubMed · DOI
6Li H et al. (2011). Blood pressure lowering effect of a pea protein hydrolysate in hypertensive rats and humans. J Agric Food Chem. PubMed · DOI
7Kohno M et al. (2006). Decreases in serum triacylglycerol and visceral fat mediated by dietary soybean β-conglycinin. J Atheroscler Thromb. PubMed · DOI
8Kaneko K et al. (2010). Orally administered soymorphins, soy-derived opioid peptides, suppress feeding and intestinal transit via gut μ1-receptor coupled to 5-HT1A, D2, and GABAB systems. Am J Physiol Gastrointest Liver Physiol. PubMed · DOI
9Chatterjee C, Gleddie S, Xiao CW (2018). Soybean bioactive peptides and their functional properties. Nutrients. PubMed · DOI

† Being confirmed by our reviewers against current sources.

10Community

forum threads →

community protocols include this →

Threads and protocols are visible to members. Joining is free.

Self-reported side effects Phase 2

Not enough data yet. 0 of the 50 members needed have logged this compound for 4+ weeks. We don't show anything below 50, so no one can be identified.

11Page history

31 Oct 2026Profile published — awaiting medical review

Licensed CC BY-NC-SA 4.0. Found an error? Report it · Editorial standards — corrections are logged here.